The clinical and economic value of the dipeptide alanyl-glutamine in total parenteral nutrition of critically ill patients treated in intensive care units in Italy
Introduction: the supplementation of alanyl-glutamine dipeptide in critically ill patients necessitating total parenteral nutrition (TPN) improves clinical outcomes, reducing mortality, infection rate, and shortening ICU hospital lengths of stay (LOS), as compared to standard TPN regimens. Here we p...
Main Authors: | Maurizio Muscaritoli, Lorenzo Pradelli, Orietta Zaniolo, Sergio Iannazzo, Mario Eandi |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2009-06-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Subjects: | |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/166 |
Similar Items
-
Oral administration of alanyl-glutamine and glutamine improve random pattern dorsal skin flap survival in rats
by: Mojtaba Karimpour, et al.
Published: (2018-08-01) -
Effects of alanyl-glutamine supplementation on the small intestinal mucosa barrier in weaned piglets
by: Shen Xing, et al.
Published: (2017-02-01) -
Early Parenteral Supplementation with Glutamine Dipeptide for Acute Myeloid Leukaemia Patients Receiving High Dose Chemotherapy
by: Dina H. Selim, et al.
Published: (2015-12-01) -
Alanyl-glutamine attenuates 5-fluorouracil-induced intestinal mucositis in apolipoprotein E-deficient mice
by: C.V. Araújo, et al.
Published: (2015-06-01) -
Alanyl-Glutamine Restores Tight Junction Organization after Disruption by a Conventional Peritoneal Dialysis Fluid
by: Maria Bartosova, et al.
Published: (2020-08-01)